XML 55 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6

Stock-Based Compensation (Tables)

3 Months Ended

Jul. 28, 2012

Stock-Based Compensation [Abstract]

Schedule of Grants Made During the Period

The table below summarizes the grants made during the first quarter of fiscal 2013:

(Unaudited, shares/units in millions)		Shares/units granted		Liability/ Equity award		Settlement
Stock options		0.2		Equity		Common shares
Stock appreciation rights ("SARs")		0.1		Liability		Cash
Restricted stock units		0.2		Liability		Cash
Performance-based units		0.1		Liability		Cash
Performance-based shares		0.1		Equity		Common shares

Stock Options, Valuation Assumptions

The fair value of stock options granted during the first quarter of fiscal 2013 was calculated using the following assumptions:

(Unaudited)		7/28/12
Risk-free interest rate			0.75	%
Dividend rate			0	%
Expected life in years			5.0
Stock price volatility			83.8	%
Fair value per share		$	7.87

Stock Appreciation Rights ("SARs"). We granted 0.1 million stock appreciation rights to employees during the first quarter of fiscal 2013. SARs will be paid in cash upon vesting and as such were accounted for as liability-based awards that will be remeasured to reflect the fair value at the end of each reporting period. These awards vest at 25% per year, beginning one year from the grant date for a term of four years. The fair value for the SARs is estimated at the end of each period using the Black-Scholes option-pricing model, which requires management to make certain assumptions. The average expected life was based on the contractual term of the SARs and expected employee exercise and post-vesting employment termination trends (which is consistent with the expected life of our option awards). The risk-free rate was based on U.S. Treasury issues with a term equal to the expected life assumed at the end of the reporting period.

The fair value of the SARs granted during the first quarter of fiscal 2013 was calculated using the following assumptions:

(Unaudited)		7/28/12
Risk-free interest rate			0.75	%
Dividend rate			0	%
Expected life in years			5.0
Stock price volatility			84.0	%
Fair value per share		$	7.88

X

- Definition

Schedule of grants during the period for stock options, SARs, restricted stock units, performance-based units and performance based shares.

+ References

No definition available.

+ Details

Name:	lzb_ScheduleOfGrantsMadeDuringPeriodTableTextBlock
Namespace Prefix:	lzb_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options and SARs , including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

No definition available.

+ Details

Name:	lzb_ScheduleOfShare-BasedPaymentAwardStockOptionsAndSarsValuationAssumptionsTableTextBlock
Namespace Prefix:	lzb_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration